Correlation Between Scopus Biopharma and RenovaCare
Can any of the company-specific risk be diversified away by investing in both Scopus Biopharma and RenovaCare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scopus Biopharma and RenovaCare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scopus Biopharma and RenovaCare, you can compare the effects of market volatilities on Scopus Biopharma and RenovaCare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scopus Biopharma with a short position of RenovaCare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scopus Biopharma and RenovaCare.
Diversification Opportunities for Scopus Biopharma and RenovaCare
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Scopus and RenovaCare is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Scopus Biopharma and RenovaCare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovaCare and Scopus Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scopus Biopharma are associated (or correlated) with RenovaCare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovaCare has no effect on the direction of Scopus Biopharma i.e., Scopus Biopharma and RenovaCare go up and down completely randomly.
Pair Corralation between Scopus Biopharma and RenovaCare
If you would invest 0.01 in RenovaCare on September 1, 2024 and sell it today you would earn a total of 0.00 from holding RenovaCare or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 4.76% |
| Values | Daily Returns |
Scopus Biopharma vs. RenovaCare
Performance |
| Timeline |
| Scopus Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| RenovaCare |
Scopus Biopharma and RenovaCare Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Scopus Biopharma and RenovaCare
The main advantage of trading using opposite Scopus Biopharma and RenovaCare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scopus Biopharma position performs unexpectedly, RenovaCare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovaCare will offset losses from the drop in RenovaCare's long position.| Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
| RenovaCare vs. Brainsway | RenovaCare vs. Venus Concept | RenovaCare vs. Tactile Systems Technology | RenovaCare vs. Icecure Medical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |